checkAd

     368  0 Kommentare Horizon Pharma plc to Host Fourth Quarter 2015 Conference Call and Webcast on February 29, 2016

    DUBLIN, IRELAND--(Marketwired - Jan 29, 2016) -  Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that its fourth quarter 2015 financial results will be released on Monday, February 29, 2016. Following the announcement, Horizon's management will host a live conference call and webcast at 8 a.m. Eastern Time to review the Company's financial and operating results.

    The live webcast and a replay may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. Please connect to the Company's website at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. Alternatively, please call 1-888-338-8373 (U.S.) or 973-872-3000 (international) to listen to the conference call. The conference ID number for the live call is 39817228. Telephone replay will be available approximately two hours after the call. To access the replay, please call 1-855-859-2056 (U.S.) or 404-537-3406 (international). The conference ID number for the replay is 39817228.

    About Horizon Pharma plc
    Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets nine medicines through its orphan, primary care and rheumatology business units. Horizon Pharma's global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.

    Contacts:

    Investors:
    John Thomas
    Executive Vice President, Strategy and Investor Relations
    Investor-relations@horizonpharma.com

    Tina Ventura
    Vice President, Investor Relations
    investor-relations@horizonpharma.com

    U.S. Media:
    Geoff Curtis
    Senior Vice President, Corporate Communications
    gcurtis@horizonpharma.com

    Ireland Media:
    Ray Gordon
    Gordon MRM
    ray@gordonmrm.ie




    Diskutieren Sie über die enthaltenen Werte




    Verfasst von Marketwired
    Horizon Pharma plc to Host Fourth Quarter 2015 Conference Call and Webcast on February 29, 2016 DUBLIN, IRELAND--(Marketwired - Jan 29, 2016) -  Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines …

    Schreibe Deinen Kommentar

    Disclaimer